We are thrilled to announce exciting news: Exploration of Neuroprotective Therapy (ENT) has received its first CiteScore™ of 2.0, as released by Scopus in early June 2025. This significant milestone follows the journal's successful inclusion in the Scopus database in October 2024.

ENT Journal: https://www.scopus.com/sourceid/21101256286

CiteScore™ 2024: 2.0

CiteScore, a metric calculated by Scopus, measures the average citations received per document published in a specific journal over a certain period. For a journal newly indexed in this prominent international database, a first CiteScore of 2.0 represents an outstanding accomplishment. It serves as an early, objective indicator of the journal’s growing influence and demonstrates that published articles are attracting attention and citations within the scientific community.

This achievement reflects growing recognition for ENT and stands as a testament to the hard work of the editorial board, reviewers, and authors who have contributed to the journal's success. It strengthens ENT's position as an emerging platform for high-quality research in neuroscience and also motivates our continued commitment to publishing rigorous, impactful research and to further elevate the journal's contribution to the global neuroscience community.

Exploration of Neuroprotective Therapy welcomes more high-quality submissions from researchers and clinicians worldwide. The journal remains dedicated to providing a rapid and rigorous peer-review process and disseminating significant research advances. With Scopus indexing, we currently continue offering our Free Publication Policy to alleviate the financial burden for researchers.